TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Practice-based Opportunities for Weight Reduction Trial at University of Pennsylvania
Brief Summary: The purpose of the study is to compare three methods of achieving weight loss in primary care medical practice. The study will be conducted in six primary care practices. Weight management will be provided to a total of 390 obese patients (who have 2 or more components of the metabolic syndrome) by their own primary care providers, in conjunction with the practices' auxiliary health professionals, including medical assistants.


Options:
A: Arm Label: Personal contact (PC); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Personal contact (PC) | Arm Label: Interactive technology (IT); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Interactive technology (IT) | Intervention Type: BEHAVIORAL; Name: Personal contact (PC); Assigned to Arm(s): Personal contact (PC) | Intervention Type: BEHAVIORAL; Name: Interactive technology (IT); Assigned to Arm(s): Interactive technology (IT)
B: Arm Label: Electronic monitor + no text message; Type: PLACEBO_COMPARATOR; Interventions: Device: Electronic + no text message | Arm Label: Electronic monitor + Text message; Type: EXPERIMENTAL; Interventions: Device: Electronic monitor + text messages | Intervention Type: DEVICE; Name: Electronic + no text message; Assigned to Arm(s): Electronic monitor + no text message | Intervention Type: DEVICE; Name: Electronic monitor + text messages; Assigned to Arm(s): Electronic monitor + Text message
C: Arm Label: Ususal Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual Care | Arm Label: Breif Lifestyle Counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Brief Lifestyle Counseling | Arm Label: Enhanced Brief Lifestyle Counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Enhanced Brief Lifestyle Counseling | Intervention Type: BEHAVIORAL; Name: Usual Care; Assigned to Arm(s): Ususal Care | Intervention Type: BEHAVIORAL; Name: Brief Lifestyle Counseling; Assigned to Arm(s): Breif Lifestyle Counseling | Intervention Type: BEHAVIORAL; Name: Enhanced Brief Lifestyle Counseling; Assigned to Arm(s): Enhanced Brief Lifestyle Counseling
D: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Behavioral: Multi-component physical activity counseling program | Arm Label: Arm 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Multi-component physical activity counseling program; Assigned to Arm(s): Arm 1

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Observation of the Initial Procalcitonin Values and the Clinical Course of Patients With Acute Respiratory Tract Infections at General Medical Practices in Greater Hannover
Brief Summary: Observation of the initial Procalcitonin values and the clinical course of consecutively included patients with Acute Respiratory Tract Infections at general medical practices in greater Hannover.


Options:
A: Intervention Type: DRUG; Name: Macrolides (azithromycin or clarithromycin); Assigned to Arm(s): N/A
B: N/A
C: Arm Label: C-reactive protein test; Type: EXPERIMENTAL; Interventions: Device: C-reactive protein test | Intervention Type: DEVICE; Name: C-reactive protein test; Assigned to Arm(s): C-reactive protein test
D: Intervention Type: OTHER; Name: laboratory value procalcitonin; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Observation of the Initial Procalcitonin Values and the Clinical Course of Patients With Acute Respiratory Tract Infections at General Medical Practices in Greater Hannover
Brief Summary: Observation of the initial Procalcitonin values and the clinical course of consecutively included patients with Acute Respiratory Tract Infections at general medical practices in greater Hannover.


Options:
A: Intervention Type: PROCEDURE; Name: PCT measurement; Assigned to Arm(s): N/A
B: N/A
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Procedure: Procalcitonin guided strategy | Intervention Type: PROCEDURE; Name: Procalcitonin guided strategy; Assigned to Arm(s): 1
D: Intervention Type: OTHER; Name: laboratory value procalcitonin; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Observation of the Initial Procalcitonin Values and the Clinical Course of Patients With Acute Respiratory Tract Infections at General Medical Practices in Greater Hannover
Brief Summary: Observation of the initial Procalcitonin values and the clinical course of consecutively included patients with Acute Respiratory Tract Infections at general medical practices in greater Hannover.


Options:
A: Arm Label: iCPR2 intervention; Type: EXPERIMENTAL; Interventions: Other: iCPR2 | Arm Label: iCPR2 control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: iCPR2; Assigned to Arm(s): iCPR2 intervention
B: N/A
C: Arm Label: Procalcitonin (PCT) group; Type: EXPERIMENTAL; Interventions: Other: Procalcitonin level, Other: Results of procalcitonin (PCT) level to treating clinician, Other: Provide procalcitonin guideline to treating clinician, Other: Telephone Visit | Arm Label: Usual Care group; Type: ACTIVE_COMPARATOR; Interventions: Other: Telephone Visit | Intervention Type: OTHER; Name: Procalcitonin level; Assigned to Arm(s): Procalcitonin (PCT) group | Intervention Type: OTHER; Name: Results of procalcitonin (PCT) level to treating clinician; Assigned to Arm(s): Procalcitonin (PCT) group | Intervention Type: OTHER; Name: Provide procalcitonin guideline to treating clinician; Assigned to Arm(s): Procalcitonin (PCT) group | Intervention Type: OTHER; Name: Telephone Visit; Assigned to Arm(s): Procalcitonin (PCT) group, Usual Care group
D: Arm Label: usual care; Type: OTHER; Interventions: Device: Finger Pulse Oximeter | Arm Label: Use of C-reactive protein point of care (CRP POC) test; Type: ACTIVE_COMPARATOR; Interventions: Device: Use of C-reactive protein (CRP) point of care test, Device: Finger Pulse Oximeter | Arm Label: Brief intervention and parent leaflet; Type: ACTIVE_COMPARATOR; Interventions: Other: Brief intervention and parent leaflet, Device: Finger Pulse Oximeter | Arm Label: CRP POC test and brief intervention & parent leaflet; Type: ACTIVE_COMPARATOR; Interventions: Device: Use of C-reactive protein (CRP) point of care test, Device: Finger Pulse Oximeter | Intervention Type: DEVICE; Name: Use of C-reactive protein (CRP) point of care test; Assigned to Arm(s): CRP POC test and brief intervention & parent leaflet, Use of C-reactive protein point of care (CRP POC) test | Intervention Type: OTHER; Name: Brief intervention and parent leaflet; Assigned to Arm(s): Brief intervention and parent leaflet | Intervention Type: DEVICE; Name: Finger Pulse Oximeter; Assigned to Arm(s): Brief intervention and parent leaflet, CRP POC test and brief intervention & parent leaflet, Use of C-reactive protein point of care (CRP POC) test, usual care

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Observation of the Initial Procalcitonin Values and the Clinical Course of Patients With Acute Respiratory Tract Infections at General Medical Practices in Greater Hannover
Brief Summary: Observation of the initial Procalcitonin values and the clinical course of consecutively included patients with Acute Respiratory Tract Infections at general medical practices in greater Hannover.


Options:
A: Intervention Type: PROCEDURE; Name: PCT measurement; Assigned to Arm(s): N/A
B: Arm Label: SelPCT; Type: ACTIVE_COMPARATOR; Interventions: Drug: sodium-selenite, Procedure: Procalcitonin guided therapy | Arm Label: SelKon; Type: ACTIVE_COMPARATOR; Interventions: Drug: sodium-selenite | Arm Label: PlacPCT; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Procedure: Procalcitonin guided therapy | Arm Label: PlacKon; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: sodium-selenite; Assigned to Arm(s): SelKon, SelPCT | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): PlacKon, PlacPCT | Intervention Type: PROCEDURE; Name: Procalcitonin guided therapy; Assigned to Arm(s): PlacPCT, SelPCT
C: Intervention Type: OTHER; Name: laboratory value procalcitonin; Assigned to Arm(s): N/A
D: N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect of Intravenous Erythromycin on Gastric Emptying in Patients Undergoing Rapid Sequence Intubation for Full Stomach - A Randomised, Placebo-controlled, Double-blind Study
Brief Summary: In this study the investigators want to investigate the effect of a short intravenous infusion of Erythromycine on gastric emptying on patients considered "full stomac" and scheduled for Emergency operation. A gastroscopy will be done after intubation to controll the effect of the perfusion.


Options:
A: Arm Label: Physiologic saline; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Erythromycine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Erythromycin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Physiologic saline | Intervention Type: DRUG; Name: Erythromycin; Assigned to Arm(s): Erythromycine
B: Arm Label: Azithromycin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Azithromycin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Azithromycin; Assigned to Arm(s): Azithromycin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Azithromycin, 250 mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Macrolide Antibiotic (Azithromycin) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Macrolide Antibiotic (Azithromycin); Assigned to Arm(s): Azithromycin, 250 mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Intervention Type: DRUG; Name: Intravenous Clarithromycin; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multinational Study to Evaluate the Efficacy and Safety of Daily Tadalafil for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia
Brief Summary: The purpose of this study is to determine whether an experimental drug known as tadalafil given once daily can reduce the symptoms associated with Benign Prostatic Hyperplasia (straining, urinary frequency, feeling like your bladder is still full, etc.)


Options:
A: Intervention Type: DRUG; Name: Viagra; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): N/A
B: Arm Label: 5 milligrams (mg) Tadalafil; Type: EXPERIMENTAL; Interventions: Drug: Tadalafil | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Tadalafil; Assigned to Arm(s): 5 milligrams (mg) Tadalafil | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo tablet, Drug: Placebo capsule | Arm Label: Tadalafil 5 milligram (mg); Type: EXPERIMENTAL; Interventions: Drug: Tadalafil 5 mg | Arm Label: Tamsulosin 0.4 mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tamsulosin | Intervention Type: DRUG; Name: Tadalafil 5 mg; Assigned to Arm(s): Tadalafil 5 milligram (mg) | Intervention Type: DRUG; Name: Placebo tablet; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Tamsulosin; Assigned to Arm(s): Tamsulosin 0.4 mg | Intervention Type: DRUG; Name: Placebo capsule; Assigned to Arm(s): Placebo
D: Arm Label: Tadalafil; Type: EXPERIMENTAL; Interventions: Drug: tadalafil | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: tadalafil; Assigned to Arm(s): Tadalafil

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Oral Contraception and Ovarian Suppression in Women With Different Weights
Brief Summary: This study proposes a double blind randomized clinical trial to include normal weight and obese women who have normal ovulatory function at baseline; the investigators will randomize women to 2 widely used OCs and evaluate ovarian follicle development and circulating progesterone to assess ovarian suppression during OC use.


Options:
A: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Drug: EV/DNG (Qlaira, BAY86-5027, SH T00658K) | Arm Label: Arm 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: SH D00264A (Triquilar) | Intervention Type: DRUG; Name: EV/DNG (Qlaira, BAY86-5027, SH T00658K); Assigned to Arm(s): Arm 1 | Intervention Type: DRUG; Name: SH D00264A (Triquilar); Assigned to Arm(s): Arm 2
B: Arm Label: Normal Weight group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Low dose formulation, Drug: High dose formulation | Arm Label: Obese group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Low dose formulation, Drug: High dose formulation | Intervention Type: DRUG; Name: Low dose formulation; Assigned to Arm(s): Normal Weight group, Obese group | Intervention Type: DRUG; Name: High dose formulation; Assigned to Arm(s): Normal Weight group, Obese group
C: Arm Label: NOMAC-E2; Type: EXPERIMENTAL; Interventions: Drug: NOMAC-E2 | Arm Label: DRSP-EE; Type: ACTIVE_COMPARATOR; Interventions: Drug: DRSP-EE | Intervention Type: DRUG; Name: NOMAC-E2; Assigned to Arm(s): NOMAC-E2 | Intervention Type: DRUG; Name: DRSP-EE; Assigned to Arm(s): DRSP-EE
D: Intervention Type: BEHAVIORAL; Name: Quick start oral contraceptive initiation; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Oral Contraception and Ovarian Suppression in Women With Different Weights
Brief Summary: This study proposes a double blind randomized clinical trial to include normal weight and obese women who have normal ovulatory function at baseline; the investigators will randomize women to 2 widely used OCs and evaluate ovarian follicle development and circulating progesterone to assess ovarian suppression during OC use.


Options:
A: Arm Label: LCS12; Type: EXPERIMENTAL; Interventions: Drug: LCS12 | Arm Label: LCS16; Type: EXPERIMENTAL; Interventions: Drug: LCS16 | Intervention Type: DRUG; Name: LCS12; Assigned to Arm(s): LCS12 | Intervention Type: DRUG; Name: LCS16; Assigned to Arm(s): LCS16
B: Arm Label: AG200-15 (cycles 1-13); Type: EXPERIMENTAL; Interventions: Drug: AG200-15 (cycles 1-13) | Arm Label: Lessina crossover to AG200-15; Type: ACTIVE_COMPARATOR; Interventions: Drug: Lessina crossover to AG200-15 | Intervention Type: DRUG; Name: AG200-15 (cycles 1-13); Assigned to Arm(s): AG200-15 (cycles 1-13) | Intervention Type: DRUG; Name: Lessina crossover to AG200-15; Assigned to Arm(s): Lessina crossover to AG200-15
C: Arm Label: Normal Weight group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Low dose formulation, Drug: High dose formulation | Arm Label: Obese group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Low dose formulation, Drug: High dose formulation | Intervention Type: DRUG; Name: Low dose formulation; Assigned to Arm(s): Normal Weight group, Obese group | Intervention Type: DRUG; Name: High dose formulation; Assigned to Arm(s): Normal Weight group, Obese group
D: Arm Label: 1; Type: N/A; Interventions: N/A | Arm Label: 2; Type: N/A; Interventions: N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: Can we improve diabetes outcomes through 1) report card mailings to patients 2) point of care distribution of report cards to patients and 3) provider performance feedback with patient level data?


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: point of care patient report cards, Behavioral: Provider performance report card | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: point of care patient report cards | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Provider performance report card | Arm Label: 4; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: point of care patient report cards; Assigned to Arm(s): 1, 2 | Intervention Type: BEHAVIORAL; Name: Provider performance report card; Assigned to Arm(s): 1, 3
B: Intervention Type: BEHAVIORAL; Name: Customized Physician Intervention; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Customized Patient Intervention; Assigned to Arm(s): N/A
C: Arm Label: physician chart reminder; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Physician chart reminder | Arm Label: chart reminder, educational mat'ls, FIT; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Physician chart reminder, Behavioral: chart reminder, educational mat'ls, FIT | Arm Label: CR, ed mat'ls, FIT, phone call; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Physician chart reminder, Behavioral: CR,ed mat'ls, FIT, phone call | Intervention Type: BEHAVIORAL; Name: Physician chart reminder; Assigned to Arm(s): CR, ed mat'ls, FIT, phone call, chart reminder, educational mat'ls, FIT, physician chart reminder | Intervention Type: BEHAVIORAL; Name: chart reminder, educational mat'ls, FIT; Assigned to Arm(s): chart reminder, educational mat'ls, FIT | Intervention Type: BEHAVIORAL; Name: CR,ed mat'ls, FIT, phone call; Assigned to Arm(s): CR, ed mat'ls, FIT, phone call
D: Arm Label: Intervention Condition; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Web-Based Intervention | Arm Label: Control Condition; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Web-Based Intervention; Assigned to Arm(s): Intervention Condition

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Paliperidone ER Versus Risperidone for Neurocognitive Function in Patients With Schizophrenia: a Randomized, Open-label, Controlled Trial
Brief Summary: Primary objective: To examine whether the switch to paliperidone ER from risperidone improves cognitive function in stabilized patients with schizophrenia.

Secondary objectives: To compare the general clinical outcomes (efficacy and safety) after switching to paliperidone ER from risperidone


Options:
A: Arm Label: 1. Paliperidone ER; Type: EXPERIMENTAL; Interventions: Drug: Paliperidone ER | Arm Label: 2 Risperidone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Risperidone | Intervention Type: DRUG; Name: Paliperidone ER; Assigned to Arm(s): 1. Paliperidone ER | Intervention Type: DRUG; Name: Risperidone; Assigned to Arm(s): 2 Risperidone
B: Intervention Type: DRUG; Name: risperidone; Assigned to Arm(s): N/A
C: Intervention Type: DRUG; Name: Aripiprazole; Assigned to Arm(s): N/A
D: Arm Label: A1; Type: ACTIVE_COMPARATOR; Interventions: Drug: aripiprazole | Arm Label: A2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: aripiprazole; Assigned to Arm(s): A1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): A2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy of Tobacco Quitline for Cancer Survivors
Brief Summary: The proposed study is a two-armed randomized controlled clinical trial examining the long-term (one-year) efficacy of telephone intervention conditions for smoking cessation in a high risk medical population; namely, cancer survivors: Proactive telephone recruitment through the Childhood Cancer Survivors Survey (CCSS) St. Jude Life Study, After Completion of Therapy (ACT) Clinic and face to face recruitment at the local West Clinics will serve as the primary methods of recruitment.

The specific aims of the study :

(1) To recruit nationally a cohort of approximately 1242 smokers who are cancer survivors(621 childhood cancer survivors and 621 adult cancer survivors); 2) To determine the long-term (one year) efficacy of the intervention condition for participants randomly assigned to the Counselor-initiated versus a Self-paced QL; and (3) to find out whether treatment outcomes vary as a function of survivors' age of cancer diagnosis (survivors who diagnosed while adults vs. childhood cancer survivors who diagnosed before the age of 21).


Options:
A: Arm Label: Culturally Targeted Cessation Program; Type: EXPERIMENTAL; Interventions: Behavioral: Culturally Targeted Cessation Program | Arm Label: Non-Targeted Cessation Program; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Non-Targeted Cessation Program | Intervention Type: BEHAVIORAL; Name: Culturally Targeted Cessation Program; Assigned to Arm(s): Culturally Targeted Cessation Program | Intervention Type: BEHAVIORAL; Name: Non-Targeted Cessation Program; Assigned to Arm(s): Non-Targeted Cessation Program
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: Varenicline plus Motivational Interviewing counseling | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Varenicline without counseling | Intervention Type: OTHER; Name: Varenicline plus Motivational Interviewing counseling; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Varenicline without counseling; Assigned to Arm(s): 2
C: Arm Label: 1; Type: OTHER; Interventions: Other: Counselor-Initiated Tobacco Quit Line | Arm Label: 2; Type: OTHER; Interventions: Other: Self-Paced Tobacco Quit Line | Intervention Type: OTHER; Name: Counselor-Initiated Tobacco Quit Line; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Self-Paced Tobacco Quit Line; Assigned to Arm(s): 2
D: Intervention Type: BEHAVIORAL; Name: Coping-focused counseling telephone calls; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Strength at Home Couples Program (Formerly: PTSD-Focused Relationship Enhancement Therapy for Returning Veterans and Their Partners)
Brief Summary: The purpose of the project is to develop and test a couples-based relationship enhancement group intervention for married or partnered Operation Enduring Freedom (OEF)/Operation Iraqi Freedom (OIF)/Operation New Dawn (OND) veterans to prevent the perpetration of intimate partner aggression (IPA) among participants.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Integrated psychotherapy for PTSD and substance use | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: 12-step based supportive therapy | Intervention Type: BEHAVIORAL; Name: Integrated psychotherapy for PTSD and substance use; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: 12-step based supportive therapy; Assigned to Arm(s): 2
B: Intervention Type: BEHAVIORAL; Name: Behavior Therapy; Assigned to Arm(s): N/A
C: Arm Label: Strength at Home Couples Group; Type: EXPERIMENTAL; Interventions: Behavioral: Strength at Home Couples Group | Arm Label: Supportive Group Therapy; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Supportive Group Therapy | Intervention Type: BEHAVIORAL; Name: Strength at Home Couples Group; Assigned to Arm(s): Strength at Home Couples Group | Intervention Type: BEHAVIORAL; Name: Supportive Group Therapy; Assigned to Arm(s): Supportive Group Therapy
D: Arm Label: Control - VSLA; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Control - Mental Health; Type: OTHER; Interventions: Behavioral: Treatment as usual | Arm Label: Voluntary Savings/Loans Assoc; Type: EXPERIMENTAL; Interventions: Behavioral: Voluntary Savings/Loans Assoc | Arm Label: Cognitive Processing Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Processing Therapy | Intervention Type: BEHAVIORAL; Name: Treatment as usual; Assigned to Arm(s): Control - Mental Health | Intervention Type: BEHAVIORAL; Name: Voluntary Savings/Loans Assoc; Assigned to Arm(s): Voluntary Savings/Loans Assoc | Intervention Type: BEHAVIORAL; Name: Cognitive Processing Therapy; Assigned to Arm(s): Cognitive Processing Therapy

Answer: C